Solution structure of amyloid beta-peptide (25-35) in different media.
about
Alzheimer's disease--a panorama glimpseThe alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seedingNMR structure of the water soluble Aβ17-34 peptideFolding events in the 21-30 region of amyloid beta-protein (Abeta) studied in silicoAggregation of Aß(25-35) on DOPC and DOPC/DHA bilayers: an atomic force microscopy studyEffects of transmitters and amyloid-beta peptide on calcium signals in rat cortical astrocytes: Fura-2AM measurements and stochastic model simulationsStructural determination of Abeta25-35 micelles by molecular dynamics simulations.Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3K⁄Akt pathway.The stability of monomeric intermediates controls amyloid formation: Abeta25-35 and its N27Q mutant.Structural similarities and differences between amyloidogenic and non-amyloidogenic islet amyloid polypeptide (IAPP) sequences and implications for the dual physiological and pathological activities of these peptides.Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide.The interaction between amyloid-β peptides and anionic lipid membranes containing cholesterol and melatoninRole of β-hairpin formation in aggregation: the self-assembly of the amyloid-β(25-35) peptide.Nanoimaging for protein misfolding and related diseases.Opposing Effects of Cucurbit[7]uril and 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranose on Amyloid β25-35 Assembly.Crystallization and preliminary X-ray diffraction analysis of the Fab fragment of WO2, an antibody specific for the Abeta peptides associated with Alzheimer's disease.Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein.Investigating the Neuroprotective Effects of Turmeric Extract: Structural Interactions of β-Amyloid Peptide with Single Curcuminoids.β-Amyloid-acetylcholine molecular interaction: new role of cholinergic mediators in anti-Alzheimer therapy?Amyloid beta: structure, biology and structure-based therapeutic development.Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment.Membrane-Accelerated Amyloid-β Aggregation and Formation of Cross-β Sheets.Peptide-lipid interactions: experiments and applications.On enhancers and inhibitors of elastin-derived amyloidogenesis.Gallotannins and Tannic Acid: First Chemical Syntheses and In Vitro Inhibitory Activity on Alzheimer's Amyloid β-Peptide Aggregation.Increase in the β-Sheet Character of an Amyloidogenic Peptide upon Adsorption onto Gold and Silver Surfaces.Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.Conformational features of the Aβ42 peptide monomer and its interaction with the surrounding solvent.Hydrophobic tail length plays a pivotal role in amyloid beta (25-35) fibril-surfactant interactions.Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
P2860
Q27011749-947EC8CC-B321-4D8D-B0B0-4FA16C74DC46Q28294445-61A88637-FDD8-41DB-97A2-D4BD1E5B434DQ28382930-111D8E38-973C-4071-AE11-F8C3DDB597B0Q28383620-B761CA8F-2E24-4B95-9E42-0B77552E6800Q30421208-92E6A2D8-961C-473A-8A04-82B63D723198Q33868997-FCCE3770-1576-4005-8D69-2534A1418308Q33999447-01D40D5D-9327-4497-BF51-660285151AB1Q34501237-C171A66B-894B-4555-AFB2-71ABFFB4950EQ34546859-51B4650A-9713-41F5-8B4B-75038050A2B2Q34979345-3902885B-B276-4D76-8EA7-55F9D9CAFF4AQ34984717-0F27902C-4C16-40F3-9C08-B267B028C9CBQ35184913-1E8300F8-CFE1-4572-B311-BF5445DCADD8Q36150710-249AB4DB-340B-4DAF-8575-8ECF38641A96Q36528645-87CCE0D9-8662-44DB-85AB-52E8A3B60496Q36593981-CA306AC2-236B-423A-8189-729024E38448Q36646809-BD5F9085-F27C-494A-A82B-08C328D3B418Q37071276-5C6CD76B-9DDF-4EC3-809E-1F82F98F7993Q37526233-A269C66A-CE6D-48CF-9766-C1230A20DF63Q38842924-D0C62C19-8D9D-4E6E-A277-A9D4E750BEF4Q39437881-61169F66-390F-4BCC-A54E-051C386E417CQ41664110-6D46801D-9386-4875-B615-245BFA42C29BQ41666582-E396303D-AA84-4CAB-8233-A70708B4EBFEQ42017138-1C03C5B2-735B-4B20-8F4D-7540E2A917CFQ46191727-C4FDFE08-4260-4331-9BE9-3A6E611AD804Q46797580-338074BC-95C4-4B67-A81D-D312DC509BE5Q48050794-496DCE5D-5F2F-4F56-9042-991C146F0344Q48175839-06669CC6-8E19-4009-A29B-FF982FE42F9EQ48446186-424439FC-7974-4FAA-854F-796EC2CC5253Q51327053-408586AD-31A8-4C89-8F4E-64E1BC2570D4Q57967107-EBF3F1A0-A62F-44A7-879A-B1168A6BC1D3
P2860
Solution structure of amyloid beta-peptide (25-35) in different media.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Solution structure of amyloid beta-peptide (25-35) in different media.
@ast
Solution structure of amyloid beta-peptide (25-35) in different media.
@en
type
label
Solution structure of amyloid beta-peptide (25-35) in different media.
@ast
Solution structure of amyloid beta-peptide (25-35) in different media.
@en
prefLabel
Solution structure of amyloid beta-peptide (25-35) in different media.
@ast
Solution structure of amyloid beta-peptide (25-35) in different media.
@en
P2093
P50
P356
P1476
Solution structure of amyloid beta-peptide (25-35) in different media.
@en
P2093
Anna M D'Ursi
Giuseppe Sorrentino
Maria R Armenante
P304
P356
10.1021/JM040773O
P407
P577
2004-08-01T00:00:00Z